Recursion Pharmaceuticals Inc Clas (RXRX)
Cost of Revenue
$11.49M
Quarterly · Period ending: · USD
RXRX Cost of Revenue
Latest reported$11.49Mperiod ending
Latest reported$11.49Mperiod ending
RXRX Quarterly Cost of Revenue ($0.00 → $11.49M)
Quarterly cost of revenue
High-resolution chart · PNG
RXRX cost of revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 11,491,000 | |
| 12,490,000 | |
| 26,876,000 | |
| 29,593,000 | |
| 20,161,000 | |
| 21,829,000 | |
| 12,794,000 | |
| 12,079,000 | |
| 9,199,000 | |
| 11,166,000 | |
| 9,881,000 | |
| 10,877,000 | |
| 9,382,000 | |
| 12,448,000 | |
| 10,840,000 | |
| 15,409,000 | |
| 14,227,000 | |
| 7,799,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |